| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The persistence of Trypanosoma cruzi tissue forms was detected in the myocardium of seropositive individuals clinically diagnosed as chronic chagasic patients following endomyocardial biopsies (EMBs) processed by immunohistochemical (peroxidase-anti-peroxidase [PAP] staining) and molecular (polymerase chain reaction [PCR]) techniques. An indirect immunofluorescent technique revealed antigenic deposits in the cardiac tissue in 24 (88.9%) of 27 patients. Persistent T. cruzi amastigotes were detected by PAP staining in the myocardium of 22 (84.6%) of 26 patients. This finding was confirmed with a PCR assay specific for T. cruzi in 21 (91.3%) of 23 biopsy specimens from the same patients. Statistical analysis revealed substantial agreement between PCR and PAP techniques (k = 0.68) and the PCR and any serologic test (k = 0.77). The histopathologic study of EMB specimens from these patients revealed necrosis, inflammatory infiltrates, and fibrosis, and made it possible to detect heart abnormalities not detected by electrocardiogram and/or cineventriculogram. These indications of myocarditis were supported by the detection of T. cruzi amastigotes by the PAP technique or its genome by PCR. They suggest that although the number of parasites is low in patients with chronic Chagas' disease, their potential for heart damage may be comparable with those present during the acute phase. The urgent necessity for testing new drugs with long-term effects on T. cruzi is discussed in the context of the present results.
This article has been cited by other articles:
|
|
 |
|
  J. A. Marin-Neto, E. Cunha-Neto, B. C. Maciel, and M. V. Simoes Pathogenesis of Chronic Chagas Heart Disease Circulation, March 6, 2007; 115(9): 1109 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Michailowsky, M. R. N. Celes, A. P. Marino, A. A. Silva, L. Q. Vieira, M. A. Rossi, R. T. Gazzinelli, J. Lannes-Vieira, and J. S. Silva Intercellular Adhesion Molecule 1 Deficiency Leads to Impaired Recruitment of T Lymphocytes and Enhanced Host Susceptibility to Infection with Trypanosoma cruzi J. Immunol., July 1, 2004; 173(1): 463 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. O. Toledo, M. T. Bahia, V. M. Veloso, C. M. Carneiro, G. L. L. Machado-Coelho, C. F. Alves, H. R. Martins, R. E. Cruz, W. L. Tafuri, and M. Lana Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes J. Antimicrob. Chemother., June 1, 2004; 53(6): 1045 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. F. Marinho, D. Z. Bucci, M. L. Z. Dagli, K. R. B. Bastos, M. G. Grisotto, L. R. Sardinha, C. R. G. M. Baptista, C. Penha Goncalves, M. R. D. Lima, and J. M. Alvarez Pathology Affects Different Organs in Two Mouse Strains Chronically Infected by a Trypanosoma cruzi Clone: a Model for Genetic Studies of Chagas' Disease Infect. Immun., April 1, 2004; 72(4): 2350 - 2357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. SCHIJMAN, C. A. VIGLIANO, R. J VIOTTI, J. M. BURGOS, S. BRANDARIZ, B. E. LOCOCO, M. I. LEZE, H. A. ARMENTI, and M. J. LEVIN TRYPANOSOMA CRUZI DNA IN CARDIAC LESIONS OF ARGENTINEAN PATIENTS WITH END-STAGE CHRONIC CHAGAS HEART DISEASE Am J Trop Med Hyg, February 1, 2004; 70(2): 210 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dumonteil, J. Escobedo-Ortegon, N. Reyes-Rodriguez, A. Arjona-Torres, and M. J. Ramirez-Sierra Immunotherapy of Trypanosoma cruzi Infection with DNA Vaccines in Mice Infect. Immun., January 1, 2004; 72(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A L Basquiera, A Sembaj, A M Aguerri, M Omelianiuk, S Guzman, J Moreno Barral, T F Caeiro, R J Madoery, and O A Salomone Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction Heart, October 1, 2003; 89(10): 1186 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Michailowsky, N. M. Silva, C. D. Rocha, L. Q. Vieira, J. Lannes-Vieira, and R. T. Gazzinelli Pivotal Role of Interleukin-12 and Interferon-{gamma} Axis in Controlling Tissue Parasitism and Inflammation in the Heart and Central Nervous System during Trypanosoma cruzi Infection Am. J. Pathol., November 1, 2001; 159(5): 1723 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Solari, S. Ortiz, A. Soto, C. Arancibia, R. Campillay, M. Contreras, P. Salinas, A. Rojas, and H. Schenone Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR J. Antimicrob. Chemother., October 1, 2001; 48(4): 515 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Molina, Z. Brener, A. J. Romanha, and J. A. Urbina In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi J. Antimicrob. Chemother., July 1, 2000; 46(1): 137 - 140. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
